Actively Recruiting

Phase 3
Age: 18Years +
FEMALE
NCT03417622

Wide Margin vs. Narrow Margin in Postneoadjuvant Lumpectomy

Led by Mansoura University · Updated on 2021-02-25

370

Participants Needed

1

Research Sites

365 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Breast cancer patients often receive systemic drugs as the initial curative treatment of their disease. The initial systemic therapy leads to a variable degree of tumor shrinkage. At present, there is no evidence-based consensus among breast surgeons on the optimal extent of resection after considerable tumor shrinkage and whether resection margin should be designed according to the tumor extent before treatment or the extent after treatment. This trial will help determine the optimal extent of resection in tumors that exhibits a significant change in volume after primary systemic therapy.

CONDITIONS

Official Title

Wide Margin vs. Narrow Margin in Postneoadjuvant Lumpectomy

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Biopsy-proven diagnosis of invasive adenocarcinoma of the breast.
  • Tumor stage T1 to T4b.
  • Nodal stage N0 to N2.
  • ASA (American Society of Anesthesiologists) class I or II.
Not Eligible

You will not qualify if you...

  • Patients choosing mastectomy.
  • Patients advised by their doctor to have mastectomy.
  • Patients choosing primary surgery instead of systemic therapy.
  • Patients advised by their doctor to have primary surgery.
  • Patients with metastatic breast cancer.
  • Patients with multifocal tumors.
  • Patients with lobular neoplasia.
  • Current pregnancy or pregnancy less than 6 months before enrollment.
  • Active second cancer.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Mansoura University Oncology Center

Al Mansurah, DK, Egypt, 35516

Actively Recruiting

Loading map...

Research Team

O

Osama Hussein, MD,PhD,FEBS

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here